Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jeff Voss"'
Autor:
Julie M. Parmentier, Jeff Voss, Candace Graff, Annette Schwartz, Maria Argiriadi, Michael Friedman, Heidi S. Camp, Robert J. Padley, Jonathan S. George, Deborah Hyland, Matthew Rosebraugh, Neil Wishart, Lisa Olson, Andrew J. Long
Publikováno v:
BMC Rheumatology, Vol 2, Iss 1, Pp 1-11 (2018)
Abstract Background Anti-cytokine therapies such as adalimumab, tocilizumab, and the small molecule JAK inhibitor tofacitinib have proven that cytokines and their subsequent downstream signaling processes are important in the pathogenesis of rheumato
Externí odkaz:
https://doaj.org/article/74a65b57a23a4f92bcb3fbfd5e56a63c
Autor:
Barbara A. Hendrickson, Andrew D. Cherniack, Andrew L. Campbell, Catherine Tripp, Melim Terry L, Carolyn A. Cuff, Kenneth Kim, Chengbin Wu, Jeff Voss
Publikováno v:
Advances in Therapy
Introduction A unique anti-interleukin (IL)-13 monoclonal antibody, RPC4046, was generated on the basis of differential IL-13 receptor (R) blockade as assessed in a murine asthma model; the safety, tolerability, pharmacokinetics, and pharmacodynamics
Autor:
L. Olson, Robert J. Padley, Annette Schwartz, Matthew Rosebraugh, Deborah Hyland, Heidi S. Camp, Neil Wishart, Julie M. Parmentier, Candace Graff, Jonathan S. George, Maria A. Argiriadi, Jeff Voss, Michael M. Friedman, Andrew J. Long
Publikováno v:
BMC rheumatology
BMC Rheumatology, Vol 2, Iss 1, Pp 1-11 (2018)
BMC Rheumatology, Vol 2, Iss 1, Pp 1-11 (2018)
Background Anti-cytokine therapies such as adalimumab, tocilizumab, and the small molecule JAK inhibitor tofacitinib have proven that cytokines and their subsequent downstream signaling processes are important in the pathogenesis of rheumatoid arthri